RTsafe and ZAP Surgical Forge Strategic Partnership to Promote the Latest Advances in Cranial Radiosurgery

RTsafe April 2024

Athens, Greece and San Carlos, California, USA – 10 April, 2024

RTsafe, the leading provider of quality assurance products and services in stereotactic radiosurgery, and ZAP Surgical, the developer of the ZAP-X® Gyroscopic Radiosurgery® platform, have announced a partnership to promote advances in cranial radiosurgery. Under the terms of the agreement, RTsafe’s dosimetry phantom based on true-to-life human anatomy will be seamlessly integrated into ZAP Surgical’s existing and future global installations. This strategic alliance underscores a shared commitment to excellence, as both organizations strive to deliver optimal patient safety and value to healthcare providers and cranial radiosurgery patients alike.

The cornerstone of this partnership lies in RTsafe’s development of a specialized phantom designed specifically for use with the ZAP-X® platform that incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. This new RTsafe phantom will be officially presented at the International Stereotactic Radiosurgery Society 2024 meeting, in New York City, on May 12th. This innovative solution will play a pivotal role in commissioning, training, educational initiatives, confidence building, periodic quality assurance protocols, and patient-specific quality assurance, reinforcing the state-of-the-art capabilities of ZAP-X.

Evangelos Pappas, Founder of RTsafe, expressed his enthusiasm for the collaboration, stating, “We are thrilled to join forces with ZAP Surgical in this transformative endeavour. By harnessing the power of our advanced phantom technology, we aim to elevate the standard of care in cranial radiosurgery and to highlight the unparalleled value of the ZAP-X platform”.

Renowned neurosurgeon and Founder of ZAP Surgical, Dr. John Adler, echoed Pappas’s sentiments, emphasizing the impact of this partnership on the future of radiosurgical practice. “At ZAP Surgical, we are dedicated to pushing the boundaries of innovation in the field of radiosurgery. By integrating RTsafe’s cutting-edge phantom technology into our systems, we are reinforcing our commitment to excellence and ensuring that clinicians worldwide have access to the most advanced tools for delivering exceptional patient care.” The collaboration between RTsafe and ZAP Surgical is a testament to the power of innovation and collaboration in healthcare.

About RTsafe

RTsafe is a medical technology company that has developed a unique approach to quality assurance that is making a contribution to the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo-in-vivo dosimetry phantoms for use in end-to-end commissioning, benchmarking, and patient-specific quality assurance in stereotactic radiotherapy. The anatomically accurate effigies enable medical professionals to simulate therapeutic interventions for each patient ahead of actual treatment and help radiotherapy technology innovators to verify the performance of their products. See www.rt-safe.com.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Dr. Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. See www.zapsurgical.com


For further information please contact:

Gareth Zundel, Marketing Director, RTsafe

[email protected] +44 7967 678309

DISCLAIMER: The statements and articles in the corporate news forum do not necessarily reflect the views of, and are not endorsed by ISRS.